Niki Momin
Family · la Jolla, CANPI 1427724962
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,090 of the $3,173 with a category attached, or 65.9%. 21 manufacturers reported payments, led by Livanova USA, Inc. at 43.0% of the total. Reporting peaked in 2022 at $2,307 and has fallen 98.9% since, to $24 in 2024. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $35.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- AbbVie$489
- Amgen$315
- Lundbeck LLC$216
- SK Life Science, Inc.$212
- Neurocrine Biosciences, Inc.$91
- plus $488 from 15 others
What the payments were for
- Travel & lodging$1,08334%
- Food & beverage$2,09066%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 5 | $1,363 |
| AbbVie | 22 | $489 |
| Amgen | 11 | $315 |
| Lundbeck LLC | 9 | $216 |
| SK Life Science, Inc. | 14 | $212 |
| Neurocrine Biosciences, Inc. | 3 | $91 |
| Argenx US, Inc. | 3 | $76 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $71 |
| CSL Behring | 4 | $56 |
| AstraZeneca | 2 | $46 |
| Lilly USA, LLC | 3 | $42 |
| Catalyst Pharmaceuticals, Inc. | 1 | $26 |
| Acorda Therapeutics, Inc | 1 | $26 |
| MDD US Operations, LLC | 1 | $25 |
| Avion Pharmaceuticals | 1 | $24 |
| Grifols USA, LLC | 1 | $18 |
| Sanofi | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Neurelis, Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,363
- UBRELVY$125
- AIMOVIG$124
How this compares
$3,173 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 18 | $470 |
Paid to pharmacies, not to this prescriber.
Other family in la Jolla
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.